LOXL2 and neoplasm: Aberrant expression of LOXL2 was often associated with elevated metastasis potency of tumor cells, and the outcome was reported as a poor prognosis in various kinds of malignancies including gastric cancer, head and neck squamous cancer, and breast cancer [6–8].